08:00 , Nov 14, 2013 |  BC Innovations  |  Distillery Therapeutics

Indication: Inflammation

Indication Target/marker/pathway Summary Licensing status Publication and contact information Inflammation Inflammation Hypoxia-inducible factor 1a subunit inhibitor (HIF1AN; FIH1); hypoxia-inducible factor prolyl hydroxylase 1 (EGLN2; HIF-PH1; PHD1) In...
07:00 , Apr 22, 2010 |  BC Innovations  |  Distillery Therapeutics

Indication: Endocrine disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Endocrine disease Diabetes; obesity Hypoxia-inducible factor 1a subunit inhibitor (HIF1AN; FIH) A study in mice suggests that inhibiting...